中国实用口腔科杂志 ›› 2026, Vol. 19 ›› Issue (4): 465-474.DOI: 10.19538/j.kq.2026.04.013

• 论著 • 上一篇    下一篇

小鼠鳞状细胞癌细胞源性细胞外囊泡预处理对口腔鳞状细胞癌原位移植瘤生长影响研究

张苗苗a,李若玮b,周一帆b,陈日新a,闫福华a,王    翔c   

  1. 南京大学医学院附属口腔医院·南京市口腔医院a牙周病科,b牙体牙髓病科,c口腔黏膜病科;南京大学口腔医学研究所,江苏 南京 210008
  • 出版日期:2026-07-30 发布日期:2026-07-30
  • 通讯作者: 王翔,闫福华
  • 基金资助:
    江苏省卫生健康委重点项目(K2024013)

  • Online:2026-07-30 Published:2026-07-30

摘要: 目的    研究小鼠鳞状细胞癌(squamous cell carcinoma,SCC)细胞源性细胞外囊泡(extracellular vesicles,EVs)预处理对口腔鳞状细胞癌(oral squamous cell carcinoma,OSCC)原位移植瘤生长的影响,初探其免疫调节作用及抗肿瘤分子机制。方法    研究于2025年1—9月在江苏艾菱菲生物科技有限公司进行。采用超速离心法提取SCC7细胞源性EVs,通过透射电镜、纳米颗粒跟踪分析及蛋白质印迹法进行鉴定。选取6周龄雌鼠30只,随机分为对照组、GW4869(一种中性鞘磷脂酶抑制剂)组和EVs组,每组10只。EVs组、GW4869组、对照组小鼠每2 d于颊部分别注射10 µg EVs、GW4869、PBS 1次,连续干预4周后移植SCC7细胞。移植后7、9、11、13、15、17、19、21 d观察并记录肿瘤形成及生长情况。实验第7周,麻醉小鼠后经眼球取血,采用酶联免疫吸附试验检测白细胞介素(interleukin,IL)-6、IL-10、IL-17A、干扰素-γ(interferon-gamma,INF-γ)、转化生长因子-β1(transforming growth factor-beta 1,TGF-β1)、程序性死亡配体1(programmed death-ligand 1,PD-L1)及肿瘤坏死因子-α(tumor necrosis factor-alpha,TNF-α)的表达情况。过量麻醉处死小鼠后完整剥离双侧颈部引流淋巴结和肿瘤,测量其体积。采用苏木精-伊红染色法分别测定肿瘤组织内液化坏死和炎症细胞浸润面积占比;采用荧光定量逆转录聚合酶链式反应检测分化簇(cluster of differentiation,CD)86、CD206、IL-6、IL-10、TGF-β1、TNF-α的mRNA表达情况;采用免疫荧光检测并统计CD206和CD8平均荧光强度、F4/80+CD206+共定位面积及CD8+ T细胞数量。结果 SCC7细胞源性EVs呈经典双层杯状结构,粒径主要分布在100 ~ 150 nm,特异性表达EVs经典阳性标志物TSG101、CD63、CD9。不同组小鼠体质量、肿瘤体积随时间的变化趋势存在显著差异(均P < 0.05)。处死小鼠后实验结果显示,对照组与GW4869组均形成原位移植瘤,EVs组原位移植瘤发生率为60%(6/10);3组肿瘤发生率比较,差异有统计学意义(χ2 = 9.231,P = 0.010)。与对照组和GW4869组比较,EVs组肿瘤体积、淋巴结转移体积、液化坏死面积占比、炎症细胞浸润面积占比、CD206平均荧光强度、F4/80+CD206+共定位面积均较小,IL-6和IL-10质量浓度、CD206和IL-10 mRNA相对表达量均较低;EVs组IL-17A和IFN-γ质量浓度、CD86和TNF-α mRNA相对表达量均较高,CD8平均荧光强度、CD8+ T细胞数量均增加,差异均有统计学意义(均P < 0.05)。对照组与GW4869组以上指标(除肿瘤体积外)比较,差异均无统计学意义(均P > 0.05)。结论    SCC7细胞源性EVs预处理可抑制小鼠OSCC原位移植瘤的生长与转移,促进巨噬细胞向M1型极化、抑制其向M2型极化,增强CD8+ T细胞肿瘤浸润,并可调节外周血炎性因子表达,为OSCC的防治提供新研究方向。

关键词: 口腔鳞状细胞癌, 细胞外囊泡, GW4869, 免疫原性, 抗肿瘤免疫反应

Abstract: Objective    To investigate the effects of pretreatment with extracellular vesicles(EVs)derived from mouse squamous cell carcinoma(SCC)cells on the growth of orthotopic xenograft tumor,and to explore the immunomodulatory effects and potential molecular mechanisms underlying the antitumor activity. Methods    The study was conducted at Jiangsu Ailingfei Biotechnology Co.,Ltd. from January to September 2025. SCC7 cell-derived EVs were isolated via ultracentrifugation and characterized by transmission electron microscopy,nanoparticle tracking analysis,and Western blotting. Thirty six-week-old female mice were chosen and randomly assigned to three groups(10 mice per group):a control group,a GW4869(a selective neutral sphingomyelinase inhibitor)treatment group,and an EVs pretreatment group. Mice in the EVs group,GW4869 group,and control group received intrabuccal injections of 10 µg EVs,GW4869,and PBS respectively,once every two days for four consecutive weeks prior to SCC7 cell transplantation. Tumor formation and growth were dynamically monitored and recorded on days 7,9,11,13,15,17,19,and 21 after tumor transplantation. At the seventh week of the experiment,all mice were anesthetized,and orbital blood samples were collected. The serum levels of interleukin-6(IL-6),IL-10,IL-17A,interferon-gamma(IFN-γ),transforming growth factor-beta 1(TGF-β1),programmed death-ligand 1(PD-L1),and tumor necrosis factor-alpha(TNF-α)were determined by enzyme-linked immunosorbent assay. Following euthanasia via overdose anesthesia,orthotopic tumors and bilateral cervical draining lymph nodes were completely dissected,and their volumes were measured. Hematoxylin and eosin(HE)staining was performed to evaluate the area proportions of liquefactive necrosis and inflammatory cell infiltration in tumor tissues. Fluorescent quantitative reverse transcription polymerase chain reaction was used to detect the mRNA expression of cluster of differentiation(CD)86,CD206,IL-6,IL-10,TGF-β1,and TNF-α. Immunofluorescence was applied to detect and statistically analyze the mean fluorescence intensity of CD206 and CD8,the co-localization area of F4/80+CD206+,and the number of CD8+ T cells. Results    The SCC7 cell-derived EVs exhibited typical cup-shaped bilayer membrane structures,with particle sizes mainly distributing between 100 - 150 nm,and positively expressed the classical EV biomarkers TSG101,CD63,and CD9. Significant differences existed in time-dependent body weight changes and tumor volume growth among the three groups of mice(all P < 0.05). After euthanasia,tumor formation analysis showed that both the control group and GW4869 group successfully developed orthotopic oral squamous cell carcinoma(OSCC)xenografts,whereas the tumor incidence rate in the EVs group was only 60%(6/10),with a statistically significant difference in tumor incidence among the three groups(χ2 = 9.231,P = 0.010). Compared with the control and GW4869 groups,mice in the EVs group presented smaller tumor volumes and cervical lymph node volumes,as well as reduced proportions of tumor liquefactive necrosis and inflammatory infiltration areas. In terms of immune and inflammatory indicators,the EVs group showed lower mean fluorescence intensity of CD206 and smaller co-localization area of F4/80+CD206+ cells. The EVs group also showed lower serum concentrations of IL-6 and IL-10,and lower relative mRNA expression levels of CD206 and IL-10. In contrast,the EVs group displayed elevated serum concentrations of IL-17A and IFN-γ,increased relative mRNA expression of CD86 and TNF-α,and higher CD8 fluorescence intensity and CD8+ T cell number. The differences in the above-mentioned items were all statistically significant(all P < 0.05). Except for tumor volume,no significant differences were observed in all the above immunological and inflammatory indicators between the control group and GW4869 group(all P > 0.05). Conclusion    Pretreatment with SCC7 cell-derived EVs can effectively suppress the growth and metastasis of orthotopic OSCC xenografts in mice,promote macrophage polarization toward the M1 anti-inflammatory phenotype and inhibit the polarization toward M2,increase intratumoral CD8+ T cell infiltration,and regulate peripheral inflammatory cytokine expression. This study provides a novel research direction for the prevention and treatment of OSCC.

Key words: oral squamous cell carcinoma, extracellular vesicles, GW4869, immunogenicity, anti-tumor immune response